Effect of PPAR α/γ agonist on Behavioural Alterations in 6-OHDA induced Parkinson Disease
DOI:
https://doi.org/10.22270/ijmspr.v8i2.33Keywords:
Dopaminergic Neurodegeneration, Saroglitazar, Parkinson’s disease, Substantia nigra pars, Compacta regionAbstract
AIM- The aim of present research work aimed to investigate the neuroprotective potential of saroglitazor in experimental animal model of neurodegenerative disease. MATERIAL & METHODS- Sixty Male Wistar albino rats (150-200 gm) were obtained from the Central Animal House of Pharmaceutical Sciences, India. The tablets of 4 mg Saroglitazar (SG), were weighed and finely powdered and then transferred into a 10-ml calibrated flask, dissolved in 4 ml sterile saline solution (0.9% NaCl), swirled and sonicated for 5 min, completed to volume with saline, and shaken well for 15 min immediately before administration. For the post operative care, Povidone-iodine was applied to all the animals for one week after surgery and gentamycin (7 mg/kg) were given to all animals 24 hourly for 2 days. The Rota rod unit consists of a rotating rod, 48 mm in diameter, which was divided into four parts by compartmentalization to permit the testing of four rats at a time. RESULTS- DC group showed marked (p < 0.0001) decline in fall off time as compared to NC group. On the other hand, SG-1, SG-3 and SG-10 groups showed dose dependent remarkable (p< 0.005, p<0.0001, respectively) rise in fall off time when compared to DC group. SG-1, SG-3 and SG-10 groups showed drastic (p < 0.0001) growth in forehand adjusting steps and noticeable (p < 0.001) increment in backhand adjusting steps with exception of non significant rise with SG-1 group, when compared to DC group. CONCLUSION- In brief, for the first time we report that novel dual PPAR α/γ agonist, SG inhibited 6-OHDA-induced dopaminergic Neurodegeneration and mitigated behavioral alterations in rat model of PD.Keywords: Dopaminergic Neurodegeneration, Saroglitazar, Parkinson’s disease, Substantia nigra pars, Compacta region
References
Ahmad, M., Saleem, S., Ahmad, A. S., Yousuf, S., Ansari, M. A., Khan, M. B., et al. (2005). Ginkgo biloba affords dose-dependent protection against 6- hydroxydopamine-induced parkinsonism in rats: Neurobehavioural, neurochemical and immunohistochemical evidences. Journal of Neurochemistry. 93(1), 94-104. https://doi.org/10.1111/j.1471-4159.2005.03000.x
Bernardi, M. M. and Neto, J. P. (1979). Effects of abrupt and gradual withdrawal from long-term haloperidol treatment on open field behavior of rats. Psychopharmacology. 65(3), 247-250. https://doi.org/10.1007/BF00492211
Boggio, P. S., Ferrucci, R., Rigonatti, S. P., Covre, P., Nitsche, M., Pascual-Leone, A., et al. (2006). Effects of transcranial direct current stimulation on working memory in patients with Parkinson's disease. Journal of the Neurological Sciences. 249(1), 31-38. https://doi.org/10.1016/j.jns.2006.05.062
Borlongan, C. V. and Sanberg, P. R. (1995). Elevated body swing test: A new behavioral parameter for rats with 6- hydroxydopamine-induced hemiparkinsonism. Journal of Neuroscience. 15(7 Pt 2), 5372-5378. https://doi.org/10.1523/JNEUROSCI.15-07-05372.1995
Chang, J. W., Wachtel, S. R., Young, D. and Kang, U. J. (1999). Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: Studies on medial forebrain bundle and striatal lesions. Neuroscience. 88(2), 617-628. https://doi.org/10.1016/S0306-4522(98)00217-6
Chaturvedi, R. K., Shukla, S., Seth, K., Chauhan, S., Sinha, C., Shukla, Y., et al. (2006). Neuroprotective and neurorescue effect of black tea extract in 6- hydroxydopamine-lesioned rat model of Parkinson's disease. Neurobiology of Disease. 22(2), 421-434. https://doi.org/10.1016/j.nbd.2005.12.008
Dawson, G. R. and Tricklebank, M. D. (1995). Use of the elevated plus maze in the search for novel anxiolytic agents. Trends in Pharmacological Sciences. 16(2), 33-36. https://doi.org/10.1016/S0165-6147(00)88973-7
Elbaz, A., Carcaillon, L., Kab, S. and Moisan, F. (2016). Epidemiology of Parkinson's disease. Revue Neurologique. 172(1), 14-26. https://doi.org/10.1016/j.neurol.2015.09.012
Haghdoost-Yazdi, H., Faraji, A., Fraidouni, N., Movahedi, M., Hadibeygi, E. and Vaezi, F. (2011). Significant effects of 4-aminopyridine and tetraethylammonium in the treatment of 6-hydroxydopamine-induced Parkinson's disease. Behavioural Brain Research. 223(1), 70-74. https://doi.org/10.1016/j.bbr.2011.04.021
Hsu, C. Y., Hung, C. S., Chang, H. M., Liao, W. C., Ho, S. C. and Ho, Y. J. (2015). Ceftriaxone prevents and reverses behavioral and neuronal deficits in an MPTP- induced animal model of Parkinson's disease dementia. Neuropharmacology. 91, 43-56. https://doi.org/10.1016/j.neuropharm.2014.11.023
Issa, D., Patel, V. and Sanyal, A. J. (2018). Future therapy for non-alcoholic fatty liver disease. Liver International. 38, 56-63. https://doi.org/10.1111/liv.13676
Jin, J., Albertz, J., Guo, Z., Peng, Q., Rudow, G., Troncoso, J. C., et al. (2013). Neuroprotective effects of PPAR-γ agonist rosiglitazone in N171-82Q mouse model of Huntington's disease. Journal of Neurochemistry. 125(3), 410-419. https://doi.org/10.1111/jnc.12190
Jung, T. W., Lee, J. Y., Shim, W. S., Kang, E. S., Kim, S. K., Ahn, C. W., et al. (2006). Rosiglitazone relieves acute ethanol-induced hangover in Sprague-Dawley rats. Alcohol and Alcoholism. 41(3), 231-235. https://doi.org/10.1093/alcalc/agl013
Kalonia, H., Kumar, P. and Kumar, A. (2010). Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: Possible role of peroxisome proliferator activated receptor-υ (PPARυ) in Huntington's disease. Pharmacology Biochemistry and Behavior. 96(2), 115- 124. https://doi.org/10.1016/j.pbb.2010.04.018
Prema, A., Janakiraman, U., Manivasagam, T. and Arokiasamy, J. T. (2015). Neuroprotective effect of lycopene against MPTP induced experimental Parkinson's disease in mice. Neuroscience Letters. 599, 12-19. https://doi.org/10.1016/j.neulet.2015.05.024
Przedborski, S., Jackson-Lewis, V., Yokoyama, R., Shibata, T., Dawson, V. L. and Dawson, T. M. (1996). Role of neuronal nitric oxide in 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 93(10), 4565-4571. https://doi.org/10.1073/pnas.93.10.4565
Rozas, G., López-Martín, E., Guerra, M. J. and Labandeira-García, J. L. (1998). The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism. Journal of Neuroscience Methods. 83(2), 165-175. https://doi.org/10.1016/S0165-0270(98)00078-8
Schallert, T., Fleming, S. M., Leasure, J. L., Tillerson, J. L. and Bland, S. T. (2000). CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology. 39(5), 777-787. https://doi.org/10.1016/S0028-3908(00)00005-8
Schallert, T., Norton, D. and Jones, T. A. (1992). A Clinically Relevant Unilateral Rat Model of Parkinsonian Akinesia. Journal of Neural Transplantation and Plasticity. 3(4), 332-333. https://doi.org/10.1155/NP.1992.332
Suliman, H. B., Carraway, M. S., Welty-Wolf, K. E., Whorton, A. R. and Piantadosi, C. A. (2003). Lipopolysaccharide Stimulates Mitochondrial Biogenesis via Activation of Nuclear Respiratory Factor-1. Journal of Biological Chemistry. 278(42), 41510-41518. https://doi.org/10.1074/jbc.M304719200
Sundari, A., & Jayakumararaj, R. Herbal Remedies Used to Treat Skin Disorders in Arasankulam Region of Thoothukudi District in Tamil Nadu, India. Journal of Drug Delivery and Therapeutics, 2020; 10(5):33-38. https://doi.org/10.22270/jddt.v10i5.4277
Wang, W. F., Wu, S. L., Liou, Y. M., Wang, A. L., Pawlak, C. R. and Ho, Y. J. (2009). MPTP Lesion Causes Neuroinflammation and Deficits in Object Recognition in Wistar Rats. Behavioral Neuroscience. 123(6), 1261-1270. https://doi.org/10.1037/a0017401
Whishaw, I. Q., Li, K., Whishaw, P. A., Gorny, B. and Metz, G. A. (2008). Use of rotorod as a method for the qualitative analysis of walking in rat. Journal of Visualized Experiments. (22), 1030. https://doi.org/10.3791/1030
Published
How to Cite
Issue
Section
Copyright (c) 2022 Nancy Joshi, Neetesh Kumar Jain, Narendra Silawat
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
.